Back

Junctophilin-2 promotes cardiomyocyte survival by blocking MURF1-mediated Junctin ubiquitination and proteasome-dependent degradation

Ji, X.; Huang, Y.; Ni, R.; Zheng, D.; Fan, G.-C.; Jones, D.; Song, L.-S.; Chakrabarti, S.; Su, Z.; Peng, T.

2022-10-24 molecular biology
10.1101/2022.10.23.513420 bioRxiv
Show abstract

AimsJunctophilin-2 is required for the development, maturation and integrity of the t-tubule system and the gating stability of RyR2 in cardiomyocytes. This study investigated whether and how junctophilin-2 maintained junctin, a scaffold protein stabilizing RyR2, to prevent cardiomyocyte death under stress. MethodsCardiomyocytes were exposed to conditions of stress including palmitate, doxorubicin, or hypoxia/re-oxygenation. Adenoviral vectors were employed to manipulate expression of junctophilin-2 and junctin in cardiomyocytes. Molecular/cellular/biochemical analyses were conducted. ResultsDifferent conditions of stress decreased junctophilin-2 expression through aberrant autophagy and concomitantly induced a reduction of junctin protein in cardiomyocytes. Over-expression of junctophilin-2 preserved the protein levels of junctin and attenuated cytosolic Ca2+ and apoptosis in cardiomyocytes under stress. Knockdown of junctophilin-2 reproduced the detrimental phenotypes of stress in cardiomyocytes. Notably, over-expression of junctin prevented cardiomyocyte death under stress whereas knockdown of junctin offset the protective effects conferred by junctophilin-2 over-expression. Mechanistically, junctophilin-2 blocked MURF1-junctin interaction thereby preventing junctin ubiquitination and proteasome-dependent degradation. Mass spectrometry analysis identified multiple ubiquitination sites on the junctin protein and the non-ubiquitinated junctin mutant (K8A/K102A/K107A/K140A) was resistant to degradation. ConclusionsThis study uncovers an unrecognized role of junctophilin-2 in preventing junctin ubiquitination and degradation in maintaining cytosolic Ca2+ homeostasis. Both junctophilin-2 and junctin represent two new survival factors of cardiomyocytes and thus, may be new therapeutic targets for cardiac protection.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Journal of Molecular and Cellular Cardiology
39 papers in training set
Top 0.1%
41.8%
2
International Journal of Molecular Sciences
453 papers in training set
Top 4%
2.5%
3
Journal of the American Heart Association
119 papers in training set
Top 2%
2.5%
4
BMC Cardiovascular Disorders
14 papers in training set
Top 0.7%
2.2%
5
PLOS ONE
4510 papers in training set
Top 47%
2.2%
50% of probability mass above
6
JACC: Basic to Translational Science
15 papers in training set
Top 0.1%
1.8%
7
Human Molecular Genetics
130 papers in training set
Top 2%
1.8%
8
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 2%
1.8%
9
Circulation: Heart Failure
14 papers in training set
Top 0.2%
1.8%
10
Circulation
66 papers in training set
Top 1%
1.8%
11
Cells
232 papers in training set
Top 3%
1.6%
12
Journal of Cellular Physiology
21 papers in training set
Top 0.3%
1.4%
13
Scientific Reports
3102 papers in training set
Top 65%
1.3%
14
Molecular Therapy - Nucleic Acids
24 papers in training set
Top 0.2%
1.3%
15
Pharmacological Research
15 papers in training set
Top 0.1%
1.0%
16
Nature Communications
4913 papers in training set
Top 58%
0.9%
17
Cellular Signalling
14 papers in training set
Top 0.1%
0.9%
18
Free Radical Biology and Medicine
33 papers in training set
Top 0.3%
0.8%
19
Aging Cell
144 papers in training set
Top 3%
0.8%
20
European Heart Journal
16 papers in training set
Top 0.7%
0.8%
21
Frontiers in Physiology
93 papers in training set
Top 5%
0.8%
22
American Journal of Physiology-Heart and Circulatory Physiology
32 papers in training set
Top 1%
0.8%
23
Atherosclerosis
29 papers in training set
Top 1%
0.8%
24
eLife
5422 papers in training set
Top 55%
0.8%
25
Circulation Research
39 papers in training set
Top 1%
0.8%
26
Biomolecules
95 papers in training set
Top 2%
0.8%
27
EMBO reports
136 papers in training set
Top 6%
0.8%
28
Cell Death & Disease
126 papers in training set
Top 2%
0.8%
29
European Journal of Pharmacology
11 papers in training set
Top 0.5%
0.7%
30
Molecular Pharmacology
15 papers in training set
Top 0.1%
0.7%